GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akdital (CAS:AKT) » Definitions » EBITDA Margin %

Akdital (CAS:AKT) EBITDA Margin % : 26.13% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Akdital EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Akdital's EBITDA for the six months ended in Jun. 2023 was MAD216 Mil. Akdital's Revenue for the six months ended in Jun. 2023 was MAD828 Mil. Therefore, Akdital's EBITDA margin for the quarter that ended in Jun. 2023 was 26.13%.


Akdital EBITDA Margin % Historical Data

The historical data trend for Akdital's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akdital EBITDA Margin % Chart

Akdital Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
20.85 25.72 24.75 27.15

Akdital Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EBITDA Margin % Get a 7-Day Free Trial 11.06 17.05 11.65 22.09 26.13

Competitive Comparison of Akdital's EBITDA Margin %

For the Medical Care Facilities subindustry, Akdital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akdital's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Akdital's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Akdital's EBITDA Margin % falls into.



Akdital EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Akdital's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=280.935/1034.778
=27.15 %

Akdital's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=216.249/827.692
=26.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akdital  (CAS:AKT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Akdital EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Akdital's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Akdital (CAS:AKT) Business Description

Traded in Other Exchanges
N/A
Address
258 Route de l’Oasis, Casablanca, MAR, 20250
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, neurosurgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.

Akdital (CAS:AKT) Headlines

From GuruFocus

Ambac to Release Fourth Quarter 2022 Results on February 28, 2023

By Business Wire Business Wire 02-14-2023

Xchange Benefits Launches Xchange Re Underwriting Agency, LLC

By Business Wire Business Wire 01-17-2023

Ambac Names Naveen Anand President of Cirrata Group

By Business Wire Business Wire 05-09-2023

Everspan Names Darwin Lucas Chief Underwriting and Reinsurance Officer

By Business Wire Business Wire 01-05-2023

Ambac Names John Tatum Business Development Officer for Cirrata Group

By Business Wire Business Wire 01-31-2023

Ambac Acquires Riverton Insurance Agency Corp.

By Business Wire 08-07-2023

Ambac to Release Third Quarter 2022 Results on November 8, 2022

By Business Wire Business Wire 10-25-2022